Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Fast CBD Relief is a topical analgesic product, often marketed under the brand Hempvana, that combines cannabidiol (CBD) with other active ingredients such as menthol or lidocaine to provide localized pain relief. The product is designed for the temporary relief of minor aches and pains associated with arthritis, backache, strains, and sprains. CBD, a non-psychoactive cannabinoid derived from the hemp plant, is believed to interact with the endocannabinoid system and various ion channels to modulate pain and inflammation. The formulation typically includes skin-conditioning agents and is intended for topical application to the affected area. While widely available as an over-the-counter (OTC) topical treatment, it is classified as a dietary supplement or a topical cosmetic/drug depending on the specific active ingredients and marketing claims.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Fast CBD Relief.